الصحة والعلوم الشرق الأوسط
Vitamin D deficiency may threaten heart health
The Passion of Youth and the Wisdom of Elders: A Prescription for Maintaining Enthusiasm as We Age
Sudan Match Sparks Controversy with Players in Galabiyas and Referees Using Whips
Lamia Yamal's friend gains attention in Spain's victory over France
What happens to blood sugar levels when eating eggs regularly
المصدر: الصحة والعلوم الشرق الأوسط
6 Hrsجاهز للتشغيل
جاهز للتشغيل
The research focuses on developing a drug called "Trontineumab", aimed at preventing Alzheimer's disease by removing "amyloid" plaques in the brain before symptoms appear. Experiments have shown that the drug can reduce plaques in just three months and it is currently being tested in a trial involving 1,600 at-risk individuals. The drug is administered via monthly intravenous injections and is expected to help prevent the progression of dementia and improve early diagnosis through blood tests that can identify those most susceptible to the disease, with the potential to activate early treatment strategies in the future.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading